BRAF and c-kit gene copy number in mutation-positive malignant melanoma

Human Pathology
Carlynn Willmore-PayneLester J Layfield

Abstract

Activating mutations in BRAF or c-kit have been reported in malignant melanoma. Because the activating mutations are dominant, it has been assumed that they are heterozygous in the affected tumors. To test this, we have carefully examined the DNA sequencing electropherograms on 43 BRAF mutation-positive and 3 c-kit mutation-positive malignant melanomas to determine the ratio of the normal to mutant allele. Of the 43 BRAF mutation-positive tumors, we classified 26 as presumptive heterozygous. Eight cases were indeterminate. Surprisingly, 9 cases appeared to contain an excess of the mutant allele. BRAF fluorescence in situ hybridization on these 9 cases suggested the increased amount of the mutant BRAF allele was due to amplification (2 cases) or chromosome 7 polysomy (7 cases). We have previously described the presence of the c-kit-activating mutation, L576P, in 2 of 100 malignant melanomas. In this report, we have evaluated an additional 53 cases and found 1 additional case that contained the L576P mutation. Evaluation of the DNA sequencing electropherograms from all 3 cases of L576P mutation-positive melanoma suggests a selective loss of the normal allele. Fluorescence in situ hybridization for c-kit on these 3 L576P mutation-...Continue Reading

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jun 26, 2003·The Journal of Biological Chemistry·Clifford D MolDuncan E McRee
Sep 26, 2003·Oncogene·Toshihiko FukushimaSeiichi Takenoshita
Dec 18, 2003·Journal of the National Cancer Institute·Janet L MaldonadoBoris C Bastian
Jan 8, 2004·The Journal of Investigative Dermatology·Amir S YazdiChristian A Sander
Apr 3, 2004·Journal of Medical Genetics·R H EdwardsB L Weber
Jun 23, 2004·Oncogene·Maria KarasaridesRichard Marais
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Sep 3, 2004·Nature Reviews. Cancer·Nick J DibbClifford D Mol
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L CorlessMichael C Heinrich
Oct 1, 2004·Nature·Philip StephensMichael R Stratton
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip Th WentGuido Sauter
Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar
May 5, 2005·Journal of the National Cancer Institute·Federico CappuzzoMarileila Varella-Garcia
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd

❮ Previous
Next ❯

Citations

Jun 28, 2012·Head and Neck Pathology·Hong Gang LiuBeverly Y Wang
Mar 14, 2009·Nature Genetics·David DankortMarcus Bosenberg
Aug 29, 2007·Oncogene·C MichaloglouD S Peeper
Apr 30, 2009·Annual Review of Pathology·Nageatte Ibrahim, Frank G Haluska
Aug 13, 2009·Molecular Cancer Therapeutics·Scott E WoodmanMichael A Davies
Oct 24, 2012·Leukemia & Lymphoma·Billy Michael Chelliah JebarajThorsten Zenz
Dec 26, 2006·Expert Review of Anticancer Therapy·Joseph G Sinkovics
Feb 4, 2010·Expert Review of Dermatology·Papia Ghosh, Lynda Chin
Apr 17, 2012·Biochimica Et Biophysica Acta·Karin van den HurkVéronique J L Winnepenninckx
Apr 3, 2010·Translational Oncology·Francesca BelleudiMaria Rosaria Torrisi
Jun 1, 2010·Surgical Pathology Clinics·Joseph A HoldenLester J Layfield
Oct 23, 2009·The Journal of Investigative Dermatology·Maria C Garrido, Boris C Bastian
Oct 18, 2008·The Journal of Investigative Dermatology·Thomas L HockerHensin Tsao
May 20, 2008·Experimental and Molecular Pathology·Joseph A HoldenLester J Layfield
Dec 28, 2007·Advances in Dermatology·Lawrence KwongStephan N Wagner
Aug 11, 2007·The Journal of Molecular Diagnostics : JMD·Cynthia SpittleRobin H Edwards
Dec 30, 2006·Seminars in Diagnostic Pathology·Jerzy Lasota, Markku Miettinen
Mar 21, 2008·Pigment Cell & Melanoma Research·Dorothy C Bennett
Oct 12, 2011·Pigment Cell & Melanoma Research·Graeme J WalkerNeil F Box
Apr 19, 2011·The British Journal of Dermatology·N L SchoenewolfR Dummer
Apr 18, 2013·International Journal of Dermatology·Lucinda S Liu, Oscar R Colegio
Aug 19, 2011·Veterinary and Comparative Oncology·A MurakamiK Maruo
Oct 8, 2015·Drugs & Aging·Aljosja RogiersPascal Wolter
May 26, 2009·Hematology/oncology Clinics of North America·Michael F Berger, Levi A Garraway
May 26, 2009·Hematology/oncology Clinics of North America·Leslie A FecherKeith T Flaherty
Feb 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Miguel F SeguraEva Hernando
May 12, 2010·Biochemical Pharmacology·Scott E Woodman, Michael A Davies
Sep 14, 2015·Surgical Oncology Clinics of North America·Omar M Rashid, Jonathan S Zager
Jul 5, 2015·BMC Cancer·Zofia Hélias-RodzewiczJean-François Emile
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicola L SchoenewolfReinhard Dummer
Oct 31, 2014·The American Journal of Dermatopathology·Banu YamanGülşen Kandiloğlu
Sep 24, 2013·Lancet·Alexander M M EggermontCaroline Robert
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiDavid E Fisher
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leslie A FecherRhoda M Alani
Jun 17, 2011·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·M B KarpovaR Dummer
Jun 3, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Carlynn Willmore-PayneLester J Layfield
Sep 9, 2010·Applied Immunohistochemistry & Molecular Morphology : AIMM·Michelle L WallanderLester J Layfield
May 10, 2007·Virchows Archiv : an International Journal of Pathology·Ana PretoRaquel Seruca
Aug 12, 2006·Current Oncology Reports·Frank G Haluska, Nageatte Ibrahim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.